Understanding how the widely-abused opiate drugs influence brain function requires a better understanding of how the endogenous opioid peptides normally act as neurotransmitters and how their function is altered by chronic opiate abuse. Substantial progress has been made in defining the molecular forms, tissue distribution, specific receptors, and pharmacological actions of the endogenous opioid peptides, yet little is known about their normal physiological role in the mammalian nervous system. We need to know what controls opioid peptide release, where endogenous opioids act, and what physiological effects they normally have. During the past several years, we have been using the rodent hippocampal slice preparation as a model to study the actions of endogenous opioid peptides. In this study, we will define the effects of endogenously released opioid peptides (the dynorphins and enkephalins) on the electrophysiological properties of identified hippocampal neurons. The studies described will examine anatomical structure and physiological properties of the opioid peptide synapses present in the hippocampus. We will determine the distribution of the opioid peptides and opioid receptors using specific antisera, and we will identify the electrophysiological actions of endogenous opioid peptides at three different sites in the hippocampus. We propose to characterize the transmitter properties of 1) the endogenous dynorphins present in the granule cells which regulate excitatory transmission in the dentate gyrus, 2) the endogenous enkephalins present in perforant path axons which regulate inhibitory transmission in the dentate gyrus, 3) the endogenous dynorphins present in the mossy fiber axons which regulate excitatory transmission in the CA3 region of the hippocampus. The effects of chronic morphine and kappa agonist exposure on the functioning of the endogenous opioid system will also be determined. Information obtained from this study will allow us to construct a detailed description of the role of endogenous opioid peptides in the hippocampal neural network and provide a model of opioid neuropeptide action in normal and opiate tolerant hippocampal physiology.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004123-10
Application #
2458356
Study Section
Special Emphasis Panel (SRCD (04))
Program Officer
Lin, Yu
Project Start
1988-03-01
Project End
1999-07-31
Budget Start
1997-08-01
Budget End
1999-07-31
Support Year
10
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Pirraglia, Paul A; Hampton, John M; Rosen, Allison B et al. (2011) Psychological distress and trends in healthcare expenditures and outpatient healthcare. Am J Manag Care 17:319-28
Drake, Carrie T; Chavkin, Charles; Milner, Teresa A (2007) Opioid systems in the dentate gyrus. Prog Brain Res 163:245-63
Chavkin, Charles; Sud, Sumit; Jin, Wenzhen et al. (2004) Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations. J Pharmacol Exp Ther 308:1197-203
Jin, Wenzhen; Zhang, Jianhua; Lou, Danwen et al. (2002) C-fos-deficient mouse hippocampal CA3 pyramidal neurons exhibit both enhanced basal and kainic acid-induced excitability. Neurosci Lett 331:151-4
Rogalski, S L; Chavkin, C (2001) Eicosanoids inhibit the G-protein-gated inwardly rectifying potassium channel (Kir3) at the Na+/PIP2 gating site. J Biol Chem 276:14855-60
Terman, G W; Eastman, C L; Chavkin, C (2001) Mu opiates inhibit long-term potentiation induction in the spinal cord slice. J Neurophysiol 85:485-94
Varnado-Rhodes, Y; Gunther, J; Terman, G W et al. (2000) Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ. Proc West Pharmacol Soc 43:15-7
Chavkin, C (2000) Dynorphins are endogenous opioid peptides released from granule cells to act neurohumorly and inhibit excitatory neurotransmission in the hippocampus. Prog Brain Res 125:363-7
Terman, G W; Drake, C T; Simmons, M L et al. (2000) Opioid modulation of recurrent excitation in the hippocampal dentate gyrus. J Neurosci 20:4379-88
Kovoor, A; Celver, J; Abdryashitov, R I et al. (1999) Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. J Biol Chem 274:6831-4

Showing the most recent 10 out of 45 publications